http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ba67603c897c123453abdee2864a8cf0
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Orlova |
| name | Anna Orlova |
| given-name | Anna |
| organization-name | Department of Medicinal Chemistry, Uppsala University, 751 23 Uppsala, Sweden 1Affibody AB, Bromma;; 3Department of Oncology, Radiology, and Clinical Immunology, Rudbeck Laboratory, Uppsala University, Uppsala; and Affibody AB, Bromma, Sweden; Unit of Biomedical Radiation Sciences, Department of Oncology, Radiology, and Clinical Immunology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden Institute of Animal Breeding and Genetics, University of Veterinary Medicine Vienna, Vienna, Austria; Ludwig Boltzmann Institute for Cancer Research, Vienna, Austria Institute of Animal Breeding and Genetics, University of Veterinary Medicine, Vienna, Austria. Institute of Applied Physics RAS, Nizhny Novgorod Division of Biomedical Radiation Sciences, Department of Oncology, Radiology and Clinical Immunology, Rudbeck Laboratory, Uppsala University, S-751 85, Uppsala, Sweden Institute of Applied Physics of Russian Academy of Sciences, 46 Ulyanov St., 603950 Nizhny Novgorod, Russia Preclinical PET Platform Department of Medicinal Chemistry Faculty of Pharmacy Uppsala University 751 23 Uppsala Sweden Bernard C. K. Choi is with the Centre for Chronic Disease Prevention and Control, Public Health Agency of Canada, Ottawa, Ontario; Department of Public Health Sciences, University of Toronto, Toronto, Ontario; and the Department of Epidemiology and Community Medicine, University of Ottawa, Ottawa. John Frank is with the Institute of Population and Public Health, Canadian Institutes of Health Research, Toronto; Department of Public Health Sciences, University of Toronto, Toronto; and Institute for Work... Affibody AB, Bromma, Sweden; Unit of Biomedical Radiation Sciences, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden Division of Biomedical Radiation Sciences, Uppsala University, Uppsala, Sweden Division of Molecular Imaging, Department of Medicinal Chemistry, Uppsala University, 751 05 Uppsala, Sweden From Biomedical Radiation Sciences, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden; Division of Protein Technology, School of Biotechnology, KTH Royal Institute of Technology, Stockholm, Sweden; and Preclinical PET Platform, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden 1Affibody AB, Bromma, Sweden;; 2Department of Oncology, Radiology and Clinical Immunology, Rudbeck Laboratory, Uppsala University; and Institute of Animal Breeding and Genetics University of Veterinary Medicine Vienna Austria Division of Biomedical Radiation Sciences, Rudbeck Laboratory, Uppsala University, Sweden, School of Biotechnology, Division of Molecular Biotechnology, Royal Institute of Technology, Stockholm, Sweden, Affibody AB, Bromma, Sweden, Hospital Physics, Department of Oncology, Uppsala University Hospital, Uppsala, Sweden, and Russian Research Centrum, Institute of Biophysics, Moscow, Russia Institute of Animal Breeding and Genetics, University of Veterinary Medicine, 1210 Vienna, Austria Preclinical PET Platform, Uppsala University, Uppsala, Sweden Division of Biomedical Radiation Sciences, Rudbeck Laboratory, and Division of Nuclear Medicine, Department of Medical Sciences, Uppsala University, Uppsala, Sweden, Department of Molecular Biotechnology, Royal Institute of Technology, Stockholm, Sweden, Department of Radiopharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran, Hospital Physics, Department of Oncology, Uppsala University Hospital, Uppsala, Sweden, and Affibody AB, Stockholm, Sweden Unit of Biomedical Radiation Sciences, Rudbeck Laboratory, Medical Radiation Physics, Uppsala University Hospital, and Department of Medical Sciences, Uppsala University, Uppsala, Sweden, School of Biotechnology, Division of Molecular Biotechnology, Royal Institute of Technology, Stockholm, Sweden, and Affibody AB, Bromma, Sweden Preclinical PET Platform, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden Unit of Biomedical Radiation Sciences, Rudbeck Laboratory, Uppsala University, Sweden Institute of Applied Physics RAS, 603950 Nizhny Novgorod, Russia Department of Medicinal Chemistry, Uppsala University, SE 75183 Uppsala, Sweden Affibody AB, Bromma, Sweden. 1Affibody AB, Bromma, Sweden;; 2Division of Biomedical Radiation Sciences, Uppsala University; and Research Centrum for Oncotheranostics, Research School of Chemistry and Applied Biomedical Sciences, National Research Tomsk Polytechnic University, 634050 Tomsk, Russia Division of Biomedical Radiation Sciences, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden. Anna.Orlova@bms.uu.se Preclinical PET Platform, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden. Division of Nuclear Medicine, Department of Medical Sciences, Uppsala University, Uppsala, Sweden, Affibody AB, Bromma, Sweden, Division of Biomedical Radiation Sciences, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden, Hospital Physics, Department of Oncology, Uppsala University Hospital, Uppsala, Sweden Division of Molecular Imaging, Department of Medicinal Chemistry, Uppsala University, SE-751 83 Uppsala, Sweden Authors' Affiliations: 1Department of Immunology, Genetics and Pathology, Division of Clinical Immunology, 2Department of Radiology, Oncology and Radiation Sciences, Division of Biomedical Radiation Sciences; 3Department of Medical Chemistry, Preclinical PET Platform, Uppsala University, Uppsala; 4Alligator Bioscience AB; and 5Department of Immunotechnology, Lund University, Lund, Sweden Division of Biomedical Radiation Sciences, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden, Affibody AB, Bromma, Sweden, Division of Nuclear Medicine, Department of Medical Sciences, Uppsala University, Uppsala, Sweden, Radiation Oncology Branch, National Cancer Institute, National Institutes of Health, 10 Center Drive, Bethesda, Maryland 20892-1088, USA, and Hospital Physics, Department of Oncology, Uppsala University Hospital, Uppsala, Sweden Unit of Biomedical Radiation Sciences, Rudbeck Laboratory, Uppsala University, S-751 85 Uppsala, Sweden. Division of Biomedical Radiation Sciences, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden Department of Oncology, Radiology, and Clinical Immunology, Uppsala University, Uppsala, Sweden.; Division of Biomedical Radiation Sciences, PET and Cyclotron Unit, Rigshospitalet, Copenhagen, Denmark. Division of Molecular Imaging, Department of Medicinal Chemistry, Uppsala University, SE-75181 Uppsala, Sweden Unit of Biomedical Radiation Sciences, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden Division of Biomedical Radiation Sciences, Rudbeck Laboratory, Uppsala University, Sweden, School of Biotechnology, Division of Molecular Biotechnology, Royal Institute of Technology, Stockholm, Sweden, Affibody AB, Bromma, Sweden, Medical Radiation Physics, Uppsala University Hospital, Uppsala University, Uppsala, Sweden, and Department of Medical Sciences, Uppsala University, Uppsala, Sweden Division of Biomedical Radiation Sciences, Box 535, S-751 21, Uppsala University, Uppsala, Sweden, Uppsala University PET-Centre, Uppsala University, Uppsala, Sweden, Department of Organic Chemistry, Uppsala University, Uppsala, Sweden, Nesmeyanov Institute of Organo-Element Compounds, Moscow, Russia, RRC “Kurchatov Institute”, Moscow, Russia, and Institute for Medical Radiobiology, Paul Scherrer Institut, Villigen, Switzerland Preclinical PET Platform, Department of Medicinal Chemistry, Uppsala University, 751 05 Uppsala, Sweden 3Preclinical PET Platform, Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden. Department of Medicinal Chemistry Division of Molecular Imaging Uppsala University 75183 Uppsala Sweden Department of Chemistry, Organic Chemistry, Uppsala University, Uppsala, Sweden, Affibody AB, Bromma, Sweden, and Unit of Biomedical Radiation Sciences, Rudbecklaboratoriet, Uppsala University, S-751 85, Uppsala, Sweden Department of Medicinal Chemistry, Uppsala University, SE‑751 83 Uppsala, Sweden |
Incoming Links
Total number of triples: 253.